Mutual of America Capital Management’s Cardlytics CDLX Stock Holding History

Mutual of America Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,918	Closed	-$838K	–	1476
2022 Q3	$838K	Sell	8,918 -811	-8%	-$115K	0.01%	1054
2022 Q2	$2.17M	Sell	9,729 -73	-0.7%	-$24.4K	0.03%	841
2022 Q1	$5.39M	Buy	9,802 +575	+6%	+$347K	0.06%	493
2021 Q4	$6.1M	Buy	9,227 +2,300	+33%	+$1.76M	0.06%	453
2021 Q3	$5.82M	Buy	6,927 +918	+15%	+$931K	0.06%	444
2021 Q2	$7.63M	Buy	6,009 +812	+16%	+$916K	0.08%	321
2021 Q1	$5.7M	Sell	5,197 -36	-0.7%	-$47.5K	0.06%	425
2020 Q4	$7.47M	Buy	5,233 +1,003	+24%	+$1.07M	0.08%	283
2020 Q3	$2.98M	Buy	4,230 +450	+12%	+$327K	0.04%	619
2020 Q2	$2.65M	Buy	3,780 +1,415	+60%	+$817K	0.04%	691
2020 Q1	$827K	Buy	+2,365	New	+$1.68M	0.01%	1022

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return

GEH

General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Mutual of America Capital Management's CDLX Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 8,918 shares — an estimated $838K sold.

Mutual of America Capital Management first reported a position in CDLX in Q1 2020 and held it in 11 quarters. The position peaked at $7.63M in Q2 2021. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

Mutual of America Capital Management reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
Mutual of America Capital Management sold 8,918 Cardlytics shares in Q4 2022, an estimated $838K.
Mutual of America Capital Management first reported a position in Cardlytics in Q1 2020 and held it in 11 quarters.
Mutual of America Capital Management's Cardlytics position peaked at $7.63M in Q2 2021.
121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.